Pharmaron Beijing Co., Ltd.

SEHK:3759 Stok Raporu

Piyasa değeri: HK$51.2b

Pharmaron Beijing Yönetim

Yönetim kriter kontrolleri 4/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Boliang Lou

İcra Kurulu Başkanı

CN¥2.2m

Toplam tazminat

CEO maaş yüzdesi95.1%
CEO görev süresi8.1yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi8.1yrs
Yönetim Kurulu ortalama görev süresi8.1yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Boliang Lou'un ücretlendirmesi Pharmaron Beijing'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

CN¥2b

Jun 30 2024n/an/a

CN¥2b

Mar 31 2024n/an/a

CN¥1b

Dec 31 2023CN¥2mCN¥2m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥1b

Jan 01 2023n/an/a

CN¥1b

Sep 30 2022n/an/a

CN¥2b

Jun 30 2022n/an/a

CN¥2b

Mar 31 2022n/an/a

CN¥2b

Dec 31 2021CN¥8mCN¥2m

CN¥2b

Sep 30 2021n/an/a

CN¥1b

Jun 30 2021n/an/a

CN¥1b

Mar 31 2021n/an/a

CN¥1b

Dec 31 2020CN¥4mCN¥2m

CN¥1b

Sep 30 2020n/an/a

CN¥1b

Jun 30 2020n/an/a

CN¥865m

Mar 31 2020n/an/a

CN¥594m

Dec 31 2019CN¥3mCN¥2m

CN¥547m

Sep 30 2019n/an/a

CN¥437m

Jun 30 2019n/an/a

CN¥378m

Mar 31 2019n/an/a

CN¥346m

Dec 31 2018CN¥3mCN¥2m

CN¥333m

Tazminat ve Piyasa: Boliang's total compensation ($USD311.40K) is below average for companies of similar size in the Hong Kong market ($USD640.18K).

Tazminat ve Kazançlar: Boliang's compensation has been consistent with company performance over the past year.

CEO

Boliang Lou (61 yo)

8.1yrs

Görev süresi

CN¥2,208,000

Tazminat

Dr. Boliang Lou, Ph D serves as Chairman of the Board and Chief Executive Officer at Pharmaron, Inc. He is a Co-Founder at Pharmaron, Inc. Dr. Lou serves as the Chairman, Chief Executive Officer and Manage...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Boliang Lou
Chairman & CEOno dataCN¥2.21mVeri yok
Xiaoqiang Lou
Co-Founder8.1yrsCN¥1.91m5.66%
HK$ 2.9b
Bei Zheng
Executive VP & Executive Director8.1yrsCN¥1.60m2.12%
HK$ 1.1b
Shing Chung Li
CFO & Secretary of the Boardno dataCN¥1.96mVeri yok
Hua Yang
Chief Scientific Officer & Deputy Manager8.1yrsCN¥1.85mVeri yok
Connie Sun
Senior VP & Global Head of Business Development of Small Moleculesno dataVeri yokVeri yok
Celina Zhong
Senior Vice President of Human Resourcesno dataVeri yokVeri yok
Katherine Lee
Chief Business Officer13.8yrsVeri yokVeri yok
Stephen Lewinton
Senior Vice President of UK Operationsno dataVeri yokVeri yok
Jingqi Huang
Senior Vice President of In Vivo Pharmacologyno dataVeri yokVeri yok
Mandy Xu
Senior Vice President of DMPK2.9yrsVeri yokVeri yok
Sid Bhoopathy
Senior VP and US Head of Laboratory Services & CGT3yrsVeri yokVeri yok

8.1yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: 3759's management team is seasoned and experienced (8.1 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Boliang Lou
Chairman & CEO8.1yrsCN¥2.21mVeri yok
Xiaoqiang Lou
Co-Founder8.1yrsCN¥1.91m5.66%
HK$ 2.9b
Bei Zheng
Executive VP & Executive Director8.1yrsCN¥1.60m2.12%
HK$ 1.1b
Kexin Yang
Chairman of the Supervisory Committee8.1yrsVeri yokVeri yok
Jiaqing Li
Non Executive Director8.1yrsVeri yokVeri yok
Kwan Hung Tsang
Independent Non Executive Director5yrsCN¥300.00kVeri yok
Lan Zhang
Employee Representative Supervisor8.1yrsVeri yokVeri yok
Lihua Li
Independent Non Executive Director2.2yrsCN¥300.00k0.0042%
HK$ 2.2m
Jian Yu
Independent Non Executive Director4.3yrsCN¥300.00kVeri yok
Shu Feng
Supervisor3.9yrsVeri yokVeri yok
Qilin Zhou
Independent Non-Executive Director2.2yrsCN¥300.00kVeri yok

8.1yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 3759's board of directors are considered experienced (8.1 years average tenure).